FANJ
AST

Financial Architects (New Jersey)’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Financial Architects (New Jersey)’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-116
Closed – – 1600
2018
Q4 		$0 Hold
116
– – ﹤0.01% 1588
2018
Q3 		$0 Hold
116
– – ﹤0.01% 1594
2018
Q2 		$0 Sell
116
-4
-3% -$6 ﹤0.01% 1612
2018
Q1 		$0 Hold
120
– – ﹤0.01% 1690
2017
Q4 		$0 Hold
120
– – ﹤0.01% 1690
2017
Q3 		$0 Hold
120
– – ﹤0.01% 1694
2017
Q2 		$0 Hold
120
– – ﹤0.01% 1732
2017
Q1 		$0 Hold
120
– – ﹤0.01% 1689
2016
Q4 		$1K Hold
120
– – ﹤0.01% 1380
2016
Q3 		$1K Hold
120
– – ﹤0.01% 1441
2016
Q2 		$0 Buy
+120
New +$434 ﹤0.01% 1539

Financial Architects (New Jersey)'s AST Position: Q1 2019 in Review

Financial Architects (New Jersey) sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 116 shares.

Financial Architects (New Jersey) first reported a position in AST in Q2 2016 and held it in 11 quarters. The position peaked at $1K in Q4 2016. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Financial Architects (New Jersey) reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 116 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • Financial Architects (New Jersey) first reported a position in Asterias Biotherapeutics Inc. Series A in Q2 2016 and held it in 11 quarters.
  • Financial Architects (New Jersey)'s Asterias Biotherapeutics Inc. Series A position peaked at $1K in Q4 2016.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2019, filed 3 May 2019.